These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 29886590

  • 1. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
    Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH.
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590
    [Abstract] [Full Text] [Related]

  • 2. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
    Roitman PD, Jauk F, Farfalli GL, Albergo JI, Aponte-Tinao LA.
    Hum Pathol; 2017 May 08; 63():89-97. PubMed ID: 28235628
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS.
    Eur J Cancer; 2016 May 08; 59():1-12. PubMed ID: 26990281
    [Abstract] [Full Text] [Related]

  • 4. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J, Rosenberg AE, Bredella MA, Choy E, Hornicek FJ, Nielsen GP, Deshpande V.
    Am J Surg Pathol; 2016 Jan 08; 40(1):72-80. PubMed ID: 26414220
    [Abstract] [Full Text] [Related]

  • 5. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP.
    Eur J Cancer; 2017 May 08; 76():118-124. PubMed ID: 28324746
    [Abstract] [Full Text] [Related]

  • 6. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R.
    World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
    Rekhi B, Verma V, Gulia A, Jambhekar NA, Desai S, Juvekar SL, Bajpai J, Puri A.
    Pathol Oncol Res; 2017 Jan 04; 23(1):157-164. PubMed ID: 27722984
    [Abstract] [Full Text] [Related]

  • 8. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images.
    Yi J, Lee YH, Kim SK, Kim SH, Song HT, Shin KH, Suh JS.
    J Orthop Sci; 2018 May 04; 23(3):570-577. PubMed ID: 29429890
    [Abstract] [Full Text] [Related]

  • 9. Spectrum of histological features of Denosumab treated Giant Cell Tumor of Bone; potential pitfalls and diagnostic challenges for pathologists.
    Tariq MU, Umer M, Khan Z, Saeed J, Siddiqui MA, Din NU.
    Ann Diagn Pathol; 2020 Apr 04; 45():151479. PubMed ID: 32088577
    [Abstract] [Full Text] [Related]

  • 10. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.
    Park MJ, Ganjoo KN, Ladd AL.
    J Hand Surg Am; 2015 Aug 04; 40(8):1620-4. PubMed ID: 25935517
    [Abstract] [Full Text] [Related]

  • 11. Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy.
    Matcuk GR, Patel DB, Schein AJ, White EA, Menendez LR.
    Skeletal Radiol; 2015 Jul 04; 44(7):1027-31. PubMed ID: 25712768
    [Abstract] [Full Text] [Related]

  • 12. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL, Hansen RL, Jørgensen PH.
    Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237
    [Abstract] [Full Text] [Related]

  • 13. Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab.
    Hakozaki M, Tajino T, Yamada H, Hasegawa O, Tasaki K, Watanabe K, Konno S.
    Diagn Pathol; 2014 Jun 07; 9():111. PubMed ID: 24906559
    [Abstract] [Full Text] [Related]

  • 14. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery.
    von Borstel D, A Taguibao R, A Strle N, E Burns J.
    Skeletal Radiol; 2017 Apr 07; 46(4):571-578. PubMed ID: 28188337
    [Abstract] [Full Text] [Related]

  • 15. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.
    Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T.
    Ann Oncol; 2015 Oct 07; 26(10):2149-54. PubMed ID: 26205395
    [Abstract] [Full Text] [Related]

  • 16. Histopathological response to denosumab in giant cell tumours of bone - A review of 11 cases.
    Kumar R, Mallya V, Mandal S, Tomar R, Khurana N, Maini L.
    J Cancer Res Ther; 2023 Oct 07; 19(3):768-772. PubMed ID: 37470608
    [Abstract] [Full Text] [Related]

  • 17. A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab.
    Aponte-Tinao LA, Piuzzi NS, Roitman P, Farfalli GL.
    Clin Orthop Relat Res; 2015 Sep 07; 473(9):3050-5. PubMed ID: 25758379
    [Abstract] [Full Text] [Related]

  • 18. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P, Gaston L, Borkowska A, Stacchiotti S, Gelderblom H, Baldi GG, Palmerini E, Casali P, Gronchi A, Parry M, Campanacci DA, Scoccianti G, Wagrodzki M, Ferrari S, Dijkstra S, Pieńkowski A, Grimer R.
    Eur J Surg Oncol; 2018 Sep 07; 44(9):1384-1390. PubMed ID: 29650420
    [Abstract] [Full Text] [Related]

  • 19. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
    Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H.
    Eur Spine J; 2017 May 07; 26(Suppl 1):236-242. PubMed ID: 28396950
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation.
    Kerr DA, Brcic I, Diaz-Perez JA, Shih A, Wilky BA, Pretell-Mazzini J, Subhawong TK, Nielsen GP, Rosenberg AE.
    Am J Surg Pathol; 2021 Jan 07; 45(1):93-100. PubMed ID: 32773532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.